AI assisted Evaluation
Diagnostic TestCBCT scans were processed using AI-based software capable of:
- Automated segmentation of the lesion
- 3D reconstruction
- Volumetric calculation
NCT Number: NCT07505485
Despite these advances, CBCT interpretation remains largely qualitative and dependent on the clinician's experience. Conventional evaluation is based on two-dimensional slices and linear measurements, which may underestimate lesion complexity and spatial distribution.
Recent developments in Artificial Intelligence in Medicine have introduced automated image segmentation tools capable of identifying lesion boundaries and calculating volumetric data. These technologies allow a transition from subjective assessment to objective, reproducible quantification.
The potential clinical advantages include:
* Objective measurement of lesion size (volume in mm³) * Improved surgical planning * Enhanced prediction of anatomical involvement * Reduction of diagnostic errors * Standardization of follow-up and outcome assessment Therefore, the aim of the present study was to evaluate the clinical impact of AI-based segmentation and volumetric analysis of endosseous lesions compared to conventional CBCT interpretation.
Interested in participating?
Request Info18 year–80 year
All sexes
Interventional
Not applicable
Dr. Giuseppe D'Albis, Bari, Italy
Healthy volunteers accepted: Yes
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
CBCT scans were processed using AI-based software capable of:
Time frame: Day 1
assessment of the time required for CBCT interpretation by the surgeon. A digital stopwatch was used to record the operative time required for each procedural step, with measurements expressed in seconds, in order to obtain an objective and standardized assessment of execution time.
Time frame: Day 1
Contact information is provided by the study sponsor or research team.
Giuseppe D'Albis, Dr.
CONTACT
Saverio Capodiferro, Prof.
CONTACT
University of Bari Aldo Moro
Other
Artificial Intelligence-Based Assessment of Endosseous Lesions: A Prospective Clinical Study
Acronym: AIpreop
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT06749158
Maxillary Cyst
Cairo, Giza Governorate, Egypt
View Trial DetailsNCT06759571
Maxillary Cyst
Minya, Egypt
View Trial DetailsNCT06662604
Bone Cysts, Cysts
View Trial DetailsNCT02612740
Cysts, Maxillary Cyst
View Trial Details